DPYSL2 and acute myeloid leukemia: Here, we show that KLF4-mediated terminal differentiation of AML cells into the monocytes is mediated by a specific isoform of the DPYSL2 gene, DPYSL2A, thus providing a basis for the development of novel differentiation therapies for AML treatment in the future.